Skip to main content
Fig. 2 | Diagnostic Pathology

Fig. 2

From: TP53 mutation-mediated genomic instability induces the evolution of chemoresistance and recurrence in epithelial ovarian cancer

Fig. 2

The relationship between the presence of TP53 mutation and ovarian cancer patient prognosis. a: proportional analysis of complete, partial and no remission after the first round of chemotherapy between the TP53 mutant and wild-type groups; b: Kaplan-Meier analysis of the TP53 mutant and wild-type groups (p < 0.05); c: the ratio of 5-year progression-free survival and subsequent chemoresistance after relapse between the TP53 mutant and wild-type groups. *p < 0.05

Back to article page